Symbol Name ID |
Adora3
adenosine A3 receptor MGI:104847 |
Allelic Composition Genetic Background |
Annotated Term | Reference |
Adora3tm1Jbsn/Adora3tm1Jbsn B6.129P2-Adora3tm1Jbsn |
abnormal mast cell degranulation | J:123463 |
abnormal response/metabolism to endogenous compounds | J:123463 | |
decreased airway responsiveness | J:123463 | |
decreased circulating creatinine level | J:82054 | |
decreased susceptibility to kidney reperfusion injury | J:82054 | |
impaired neutrophil recruitment | J:123463 | |
ocular hypotension | J:78723 | |
Adora3tm1Jbsn/Adora3tm1Jbsn either: (involves: 129P2/OlaHsd * C57BL/6 * DBA/2) or (involves: 129P2/OlaHsd * C57BL/6) |
abnormal mast cell physiology | J:60293 |
decreased tumor necrosis factor secretion | J:60293 | |
Adora3tm1Jbsn/Adora3tm1Jbsn involves: 129P2/OlaHsd * C57BL/6 * DBA/2 |
abnormal nociception after inflammation | J:120442 |
abnormal response/metabolism to endogenous compounds | J:61026, J:77069 | |
decreased acute inflammation | J:120442 | |
decreased myocardial infarct size | J:103737 | |
decreased systemic arterial blood pressure | J:61026 | |
increased coronary flow rate | J:77069 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 12/10/2024 MGI 6.24 |
|
|